The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

About

Terms

 

 
 

Experiences with the use of caspofungin in paediatric patients.

Invasive fungal infections are important causes for treatment-related morbidity and mortality in severely immunocompromised paediatric patients with haematological malignancies or in children undergoing haematopoietic stem cell transplantation. In addition, neonates, in particular preterm infants, are at risk for invasive mycoses. The past decade witnessed a major expansion of antifungal drug research, which has resulted in the development of new antifungal agents. Caspofungin is the first licensed compound of the novel class of echinocandin lipopeptides. Although the compound is not yet licensed in the paediatric population, caspofungin is increasingly prescribed in children. This article reviews the clinical pharmacology of caspofungin and the published experience with the drug in neonates and immunocompromised children.[1]

References

  1. Experiences with the use of caspofungin in paediatric patients. Lehrnbecher, T., Groll, A.H. Mycoses (2008) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
 
WikiGenes - Universities